TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 142 filers reported holding TRILLIUM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $22,191,000 | +356.2% | 1,263,721 | +152.0% | 0.01% | +400.0% |
| Q2 2021 | $4,864,000 | +340.6% | 501,442 | +387.4% | 0.00% | – |
| Q1 2021 | $1,104,000 | -86.7% | 102,875 | -81.8% | 0.00% | -100.0% |
| Q4 2020 | $8,326,000 | +229.9% | 566,042 | +218.8% | 0.00% | +200.0% |
| Q3 2020 | $2,524,000 | +54.6% | 177,561 | -12.0% | 0.00% | – |
| Q2 2020 | $1,633,000 | +258.9% | 201,833 | +79.2% | 0.00% | – |
| Q1 2020 | $455,000 | – | 112,651 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 4,040,000 | $59,428,000 | 8.74% |
| Fairmount Funds Management LLC | 1,478,181 | $21,744,000 | 7.78% |
| COMMODORE CAPITAL LP | 852,871 | $12,546,000 | 6.82% |
| Ghost Tree Capital, LLC | 1,950,000 | $28,685,000 | 6.39% |
| Endurant Capital Management LP | 655,741 | $9,646,000 | 3.48% |
| FRAZIER MANAGEMENT LLC | 3,053,107 | $44,879,000 | 3.46% |
| ACUTA CAPITAL PARTNERS, LLC | 803,000 | $11,812,000 | 3.21% |
| NEA Management Company, LLC | 5,736,363 | $84,382,000 | 2.23% |
| Tri Locum Partners LP | 296,838 | $4,366,000 | 1.59% |
| Avidity Partners Management LP | 3,185,200 | $46,854,000 | 1.52% |